Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001087388 | SCV000762305 | likely benign | Biotin-responsive basal ganglia disease | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000733532 | SCV000861609 | uncertain significance | not provided | 2018-06-11 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000733532 | SCV003845520 | uncertain significance | not provided | 2023-01-05 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Prevention |
RCV003953140 | SCV004781363 | uncertain significance | SLC19A3-related disorder | 2024-06-07 | no assertion criteria provided | clinical testing | The SLC19A3 c.436G>A variant is predicted to result in the amino acid substitution p.Val146Ile. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.13% of alleles in individuals of African descent in gnomAD, including one homozygote. Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |